Tiny Protein Region Holds Key to Healthy Heartbeat, Research Suggests

A newly discovered region within a muscle protein called leiomodin may be critical for maintaining a steady heartbeat and could offer potential avenues for treating heart ailments, according to research from Washington State University (WSU). The findings, published in the journal Circulation Research, highlight the importance of this often-overlooked protein in regulating the length of filaments that control heart contractions.

How Leiomodin Impacts Heart Function

The heartbeat relies on the precise coordination of protein filaments – thick and thin filaments – within the heart muscle. These filaments bind and unbind in response to electrical signals, causing the muscle to contract and relax. The thin filaments, primarily composed of actin, are regulated in length by proteins like tropomodulin and leiomodin. Maintaining consistent filament length is crucial throughout life, but particularly important for healthy heart development in infants.

“It’s a small part of a big protein that turned out to be extremely important for its function in the elongation of thin filaments,” explained Alla Kostyukova, professor in the Gene and Linda Voiland School of Chemical Engineering and Bioengineering at WSU and one of the study’s lead researchers.¹

The ‘Leaky Cap’ Mechanism

Researchers discovered that leiomodin binds to actin filaments through a “leaky cap” mechanism. This weaker binding allows leiomodin to be removed when actin starts to polymerize, or build a protein chain. Mutations in this binding site can lead to the formation of filaments that are too long or too short, contributing to conditions like cardiomyopathy.

“In many cardiomyopathies, the length of the thin filaments is wrong. It always has to be the correct length. If you have a mutation in one of these proteins, your heart cannot work properly,” Kostyukova stated.¹

Collaboration and Future Research

The WSU research was conducted in collaboration with researchers from the University of Arizona and Mount Sinai School of Medicine in New York.¹ The team utilized nuclear magnetic resonance to analyze the protein structure with and without mutations, and collaborators at Icahn School of Medicine at Mount Sinai verified the protein’s behavior in animal cells.¹

Researchers have identified three functional sites on cardiac proteins and aim to understand how these binding sites work together in the elongation process. The ultimate goal is to develop small molecules that can improve the function of leiomodin in individuals with pathogenic mutations.¹

Understanding Leiomodin’s Role

Previous research has shown that leiomodin interacts with the cardiac thin filament in a calcium-dependent manner, regulating filament length by protecting newly formed units during contraction and promoting actin polymerization during relaxation.² The discovery of a fourth actin-binding site on leiomodin-2 further emphasizes the protein’s complex role in cardiac muscle function.⁴

This research was funded by the National Institutes of Health and the American Heart Association.¹

References

1. Kostyukova, A. (2026, February 26). Researchers discover important clue to healthy heartbeats. Washington State University News. https://news.wsu.edu/news/2026/02/26/researchers-find-important-clue-to-healthy-heartbeats/
2. Little, K. P., et al. (2025, January 30). Interaction of cardiac leiomodin with the native cardiac thin filament. PubMed. https://pubmed.ncbi.nlm.nih.gov/39883708/